---
title: "Jinhe Biotechnology recently obtained a patent for the invention of a cat vaccine, and its layout in pet health protection is becoming increasingly complete"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243043330.md"
description: "Recently, Jinhe Biotechnology announced that its subsidiary Jinhe Youben has obtained an invention patent certificate issued by the National Intellectual Property Administration, with the invention titled \"A Bivalent Subunit Vaccine for Feline Infectious Rhinotracheitis and Feline Panleukopenia and Its Preparation Method and Application.\""
datetime: "2025-06-04T06:56:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243043330.md)
  - [en](https://longbridge.com/en/news/243043330.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243043330.md)
generator: "portal-rs"
---

# Jinhe Biotechnology recently obtained a patent for the invention of a cat vaccine, and its layout in pet health protection is becoming increasingly complete

Recently, Jinhe Biotechnology announced that its subsidiary Jinhe Youben has obtained an invention patent certificate issued by the National Intellectual Property Administration, with the invention titled "A Bivalent Subunit Vaccine for Feline Infectious Rhinotracheitis and Feline Panleukopenia and Its Preparation Method and Application."

### Related Stocks

- [002688.CN](https://longbridge.com/en/quote/002688.CN.md)

## Related News & Research

- [XPENG-W  Robot Unit Raises Over USD900 Million in First Funding Round, Post-money Valuation Exceeds USD6.3 Billion](https://longbridge.com/en/news/296850376.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [08:10 ETTruvant Acquires New Jersey-Based Multi-Pak Packaging, a Specialist in Vitamins, Supplements and OTC](https://longbridge.com/en/news/296912238.md)
- [Sentinel Net Lease Announces Final Closing of Sentinel Opportunity Fund I](https://longbridge.com/en/news/296631028.md)
- [Biovica says DiviTum TKa study in metastatic melanoma is published in Clinical Cancer Research](https://longbridge.com/en/news/296871354.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**